Skip to main content
BAX logo

Baxter International Inc

Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies

Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees live and work. The Foundation helps advance Baxter's Mission to Save and Sustain Lives by partnering with organizations around the world to increase access to healthcare for the underserved, develop the next generation of innovators who will lead the way in advancing healthcare and create a positive, long-lasting impact in communities globally. For more information, please visit Baxter's Corporate Responsibility page. Baxter is a registered trademark of Baxter International Inc. or its subsidiaries. i Carey, Ben, et al., 2022, PLOS One ii Kline et al., 2020, Academic Emergency Medicine SOURCE Pet Partners

Did you know?

Free cash flow has been growing at -21.8% annually.

Current Price

$16.68

-0.60%

GoodMoat Value

$50.11

200.4% undervalued
Profile
Valuation (TTM)
Market Cap$8.57B
P/E-8.96
EV$16.27B
P/B1.40
Shares Out514.06M
P/Sales0.76
Revenue$11.24B
EV/EBITDA24.82

Baxter International Inc (BAX) Financial Statements

GoodMoat Analysis

Based on data as of March 26, 2026

Baxter International presents a challenging quality profile for a value investor, with significant profitability and leverage concerns offset by a modest free cash flow yield and dividend. The company is currently unprofitable on a GAAP basis with negative margins and returns, while carrying a high debt load.

Read full analysis
Analyzing Baxter through the GoodMoat Quality Indicators reveals several areas of weakness. The company is not GAAP profitable, reporting a negative EPS of -$1.87 and an operating margin of -2.7%, which fails the framework's profitability criterion. The negative ROE of -15.6% is far below the 15-20% threshold for a high-quality business, indicating poor returns on shareholder capital. The balance sheet is a significant concern, with a Debt/Equity ratio of 1.58, suggesting leverage is elevated and not aligned with the 'low/zero debt' quality standard. Free cash flow generation is a relative bright spot, with a FCF Yield of 3.7%, though this is just at the lower end of the framework's >10-15% FCF margin benchmark when converted. The dividend yield of 3.95% provides some return of capital. From a Growth Assessment perspective, the lack of reported YoY revenue growth data and the current negative profitability make it difficult to assess a durable growth trajectory or investment efficiency. The financial picture is one of a company under pressure, with weak core profitability metrics that would need to show clear sequential improvement to meet quality standards for a value investor. Analysis based on data as of 2024-05-15.

BAX Financial Data

EBITDA$657.00M
Revenue (TTM)$11.24B
Gross Profit (TTM)$3.38B
Gross Margin
Operating Margin-2.74%
ROE-15.61%
ROA-4.77%
Debt/Equity1.58
Current Ratio2.31
FCF$323.00M
FCF Yield3.77%
Piotroski F-Score
Rev/Share (TTM)$21.87
50-Day MA$19.05
200-Day MA$21.89
Shares Outstanding0.51B

BAX Computed Insights

FCF$323.00M
FCF Growth Rate-21.76%
EPS Growth (CAGR)-21.76%
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

BAX Financial Statements & Data

Baxter International Inc (BAX) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Baxter International Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $11.24B. Gross profit (TTM) is $3.38B. EBITDA is $657.00M. Earnings per share (EPS) is $-1.87. The P/E ratio is -8.96. Market capitalization is $8.57B.

Free cash flow (FCF) is $323.00M. FCF growth rate is -21.76%. EPS growth CAGR is -21.76%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Baxter International Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.